Mebias Discovery

OverviewSuggest Edit

Mebias Discovery is a company that develops medical research platform designed to mine the full potential of G-protein coupled receptor drugs. Its platform offers a validated, rapid and efficient drug discovery technology, enabling healthcare service providers to treat diseases such as mood and neurodegenerative disorders.

TypePrivate
Founded2015
HQPhiladelphia, US
Websitemebiasdiscovery.com

Locations

Mebias Discovery is headquartered in
Philadelphia, United States

Location Map

Latest Updates

Employees (est.) (Feb 2020)2

Mebias Discovery Office Locations

Mebias Discovery has an office in Philadelphia
Philadelphia, US (HQ)
3675 Market St #200
Show all (1)

Mebias Discovery Financials and Metrics

Summary Metrics

Founding Date

2015

Mebias Discovery total Funding

$3.5 m

Mebias Discovery latest funding size

$3.50 m

Time since last funding

4 months ago

Mebias Discovery investors

Mebias Discovery's latest funding round in October 2019 was reported to be $3.5 m. In total, Mebias Discovery has raised $3.5 m
Show all financial metrics

Mebias Discovery Online and Social Media Presence

Embed Graph

Mebias Discovery Frequently Asked Questions

  • When was Mebias Discovery founded?

    Mebias Discovery was founded in 2015.

  • How many employees does Mebias Discovery have?

    Mebias Discovery has 2 employees.

  • Who are Mebias Discovery competitors?

    Competitors of Mebias Discovery include iThera Medical, Robarts Clinical Trials and AccelLAB.

  • Where is Mebias Discovery headquarters?

    Mebias Discovery headquarters is located at 3675 Market St #200, Philadelphia.

  • Where are Mebias Discovery offices?

    Mebias Discovery has an office in Philadelphia.

  • How many offices does Mebias Discovery have?

    Mebias Discovery has 1 office.